论文信息 - Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials - 字舞流文

Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

M. Lebwohl | Z. Draelos | M. Gooderham | K. Papp | T. Jones | L. Kircik | A. Moore | D. Pariser | S. Kempers | L. Stein Gold | M. Zirwas | J. D. Del Rosso | J. Bagel | R. Higham | P. Yamauchi | N. Bhatia | D. Berk | P. Burnett | L. Green | Amy Feng | L. Ferris | Adelaide Herbert